Progressive multiple sclerosis (PMS) is an immune-initiated neurodegenerative condition
that lacks effective therapies. Although peripheral immune infiltration is a hallmark of …

Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD) is an
immune-mediated demyelinating disease that is challenging to differentiate from multiple …

Background and Objectives The diagnosis of multiple sclerosis (MS) can be challenging in
clinical practice because MS presentation can be atypical and mimicked by other diseases …

The need to improve diagnostic precision in multiple sclerosis (MS) is widely recognized. In
recent years, several novel magnetic resonance imaging (MRI) biomarkers have been …

Brain and spinal cord imaging plays a pivotal role in aiding clinicians with the diagnosis and
monitoring of multiple sclerosis. Nevertheless, the significance of magnetic resonance …

Multiple sclerosis (MS) is the most common acquired inflammatory and demyelinating
disease in adults. The conventional diagnostic of MS and the follow-up of inflammatory …

While no single test is diagnostic of multiple sclerosis (MS), the identification of hyperintense
(bright) focal lesions on T2-weighted MR imaging sequences has made MR imaging an …

Background Currently, there are no available recommendations or guidelines on how to
perform MRI monitoring in the management of neuromyelitis optica spectrum disorder …

Multiple sclerosis (MS) and neuromyelitis optica spectrum disorders (NMOSD) are distinct
demyelinating diseases of the central nervous system, each characterized by unique …

Objective Prevalence, susceptibility genes, and clinical and radiological features may differ
across different ethnic groups of multiple sclerosis (MS). We aim to characterize brain …